ChenGuang Biotech Group Co., Ltd. (300138.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 5.91B |
| Enterprise Value | 8.61B |
| P/E Ratio | 18.04 |
| PEG Ratio | 0.18 |
| Price/Sales Ratio | 0.92 |
| Price/Book Ratio | 1.75 |
| Enterprise/Revenue | 1.15 |
| Enterprise/EBITDA | 15.98 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.05 |
| Operating Margin | 0.06 |
| Return On Assets | 0.04 |
| Return On Equity | 0.1 |
| Revenue | 6.56B |
| Revenue/Share | 13.58 |
| Gross Profit | 438.91M |
| EBITDA | 624.86M |
| Net Income | 368.87M |
| Diluted EPS | 0.76 |
| Total Cash | 3.27B |
| Total Cash/Share | 6.79 |
| Total Debt | 4.43B |
| Total Debt/Equity | 1.29 |
| Current Ratio | 1.32 |
| Book Value Per Share | 7.22 |
| 52-Week Change | -7.02 |
| 52-Week High | 15.8 |
| 52-Week Low | 8.71 |
| Moving Average 50 Days | 11.82 |
| Moving Average 200 Days | 11.7 |
| Average Volume | 7.1M |
| Shares Outstanding | 483.1M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.3 |
| Trailing Annual Dividend Yield | 2.41 |
| Payout Ratio | 0.76 |
| Last Split Factor | 7:5 |
| Last Split Date | June 27, 2018 |